Hospitals are in a unique position when it comes to managing their pharmacy benefits because they often possess in-house pharmacy distribution capabilities and access to staff with clinical pharmacy expertise. If a hospital can fully leverage these types of in-house…
Pharmacy
Sen. Charles E. Schumer (D-N.Y.) has announced he will propose a bill that would allow the U.S. Department of Justice to punish "unscrupulous drug distributors" who sell drugs in severe shortages at vastly inflated prices, according to an Associated Press…
A recent report published by the Office of the Inspector General showed the Medicaid program pays significantly less than Medicare for drugs.
Medicare beneficiaries who qualify for the Medicare Low-Income Subsidy Program could be eligible this year to pay no more than $2.50 for generic drugs and $6.30 for brand name drugs, according to a CMS news release.
Across the country, hospitals and surgery centers are facing shortages of critical anesthetics and other drugs. A survey the American Society of Anesthesiologists recently conducted found more than 90 percent of anesthesiologist respondents are currently experiencing a shortage of at…
Advertisement
Pharmacists and physicians are having difficulty providing necessary medications to their patients, as nearly 200 prescriptions are on the FDA national drug shortage list, according to a WHSV report.
The American Society of Anesthesiologists' Drug Shortages Survey found more than 90 percent of anesthesiologist respondents are currently experiencing a shortage of at least one anesthetic, according to an ASA news release.
One of the largest manufacturers of injectable medications, American Regent, is suspending production of Phenylephrine HI injection of 10mL, 5mL and 1mL vials, according to an American Society of Anesthesiologists release.
Drug maker Hospira has confirmed that the company is once again producing the anesthetic Propofol, following a voluntarily recall of the anesthetic in summer 2010, according to a Chicago Tribune report.
Carestream Health plans to raise the price for medical and other X-ray film stock by up to 50 percent worldwide, due to price increases for the commodities it uses to make the film, according to a release by Carestream Health.